Nevada gets $1.5m in GlaxoSmithKline settlement
Nevada and 37 other states have reached a $90 million consent judgment with GlaxoSmithKline LLC over GlaxoSmithKline promotion of its diabetes drug, Avandia.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
Loading ...
What's On